Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Neoplasms Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Model Mathematics
Breast Neoplasms Medicine & Life Sciences
Tumor Mathematics
Pain Medicine & Life Sciences
Mortality Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2022

Research Output 1990 2017

  • 3804 Citations
  • 32 Scopus h-Index
  • 113 Article
  • 6 Review article
  • 2 Editorial
  • 1 Short survey

11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency

Turcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J. & Merke, D. P. Aug 1 2017 In : Journal of Clinical Endocrinology and Metabolism. 102, 8, p. 2701-2710 10 p.

Research output: Contribution to journalArticle

Adrenal Rest Tumor
Steroid 21-Hydroxylase
Testicular Neoplasms
Androgens
Biological Markers
Prediction
Landmarks
Model
Cox model
Joint model
1 Citations

Is prostate cancer different in black men? Answers from 3 natural history models

Tsodikov, A., Gulati, R., de Carvalho, T. M., Heijnsdijk, E. A. M., Hunter-Merrill, R. A., Mariotto, A. B., de Koning, H. J. & Etzioni, R. Jun 15 2017 In : Cancer. 123, 12, p. 2312-2319 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Incidence
SEER Program
Prostate-Specific Antigen
Health Surveys

Joint modeling of time to recurrence and cancer stage at recurrence in oncology trials

Marchenko, O., Tsodikov, A., Keener, R., Katenka, N. & Kloster Thomas, Y. May 4 2017 In : Journal of Biopharmaceutical Statistics. 27, 3, p. 507-521 15 p.

Research output: Contribution to journalArticle

Recurrence
Neoplasms
Cancer
Urinary Bladder Neoplasms
Clinical Trials
Zero
Profile likelihood
Damage
Modeling
Model